RU2016141650A3 - - Google Patents

Download PDF

Info

Publication number
RU2016141650A3
RU2016141650A3 RU2016141650A RU2016141650A RU2016141650A3 RU 2016141650 A3 RU2016141650 A3 RU 2016141650A3 RU 2016141650 A RU2016141650 A RU 2016141650A RU 2016141650 A RU2016141650 A RU 2016141650A RU 2016141650 A3 RU2016141650 A3 RU 2016141650A3
Authority
RU
Russia
Application number
RU2016141650A
Other versions
RU2684906C2 (ru
RU2016141650A (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of RU2016141650A publication Critical patent/RU2016141650A/ru
Publication of RU2016141650A3 publication Critical patent/RU2016141650A3/ru
Application granted granted Critical
Publication of RU2684906C2 publication Critical patent/RU2684906C2/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/472Non-condensed isoquinolines, e.g. papaverine
    • A61K31/4725Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
RU2016141650A 2014-03-26 2015-03-25 Амидные соединения RU2684906C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2014064590 2014-03-26
JP2014-064590 2014-03-26
PCT/JP2015/059026 WO2015147020A1 (ja) 2014-03-26 2015-03-25 アミド化合物

Publications (3)

Publication Number Publication Date
RU2016141650A RU2016141650A (ru) 2018-04-27
RU2016141650A3 true RU2016141650A3 (ru) 2018-11-12
RU2684906C2 RU2684906C2 (ru) 2019-04-16

Family

ID=54195532

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2016141650A RU2684906C2 (ru) 2014-03-26 2015-03-25 Амидные соединения

Country Status (14)

Country Link
US (1) US10106523B2 (ru)
EP (1) EP3124480B1 (ru)
JP (1) JP6428763B2 (ru)
KR (1) KR20160138098A (ru)
CN (1) CN106132945B (ru)
AR (1) AR099833A1 (ru)
CA (1) CA2943778A1 (ru)
ES (1) ES2684334T3 (ru)
MX (1) MX368098B (ru)
PL (1) PL3124480T3 (ru)
PT (1) PT3124480T (ru)
RU (1) RU2684906C2 (ru)
TW (1) TW201623277A (ru)
WO (1) WO2015147020A1 (ru)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CR20180323A (es) 2015-11-20 2018-08-06 Idorsia Pharmaceuticals Ltd Derivados de indol n-sustituídos como moduladores de los receptores de pge2
ES2893452T3 (es) 2017-05-18 2022-02-09 Idorsia Pharmaceuticals Ltd Derivados de pirimidina como moduladores del receptor de PGE2
TW201900180A (zh) 2017-05-18 2019-01-01 瑞士商愛杜西亞製藥有限公司 嘧啶衍生物
CA3063632A1 (en) 2017-05-18 2018-11-22 Idorsia Pharmaceuticals Ltd Benzofurane and benzothiophene derivatives as pge2 receptor modulators
MA49128A (fr) 2017-05-18 2021-03-17 Idorsia Pharmaceuticals Ltd Dérivés de pyrimidine utilisés en tant que modulateurs des récepteurs des pge2
PE20191787A1 (es) 2017-05-18 2019-12-24 Idorsia Pharmaceuticals Ltd Derivados de indol n-sustituidos
KR20230107228A (ko) 2020-11-13 2023-07-14 오노 야꾸힝 고교 가부시키가이샤 Ep4 길항약과 면역 체크포인트 저해 물질의 병용에 의한 암 치료

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003099857A1 (en) * 2002-05-23 2003-12-04 Theratechnologies Inc. Antagonistic peptides of prostaglandin e2 receptor subtype ep4
US8969394B2 (en) 2006-08-11 2015-03-03 Merck Frosst Canada Ltd. Thiophenecarboxamide derivatives as EP4 receptor ligands
EP2172447A4 (en) * 2007-07-03 2011-08-24 Astellas Pharma Inc amide
DK2565191T3 (da) * 2008-05-14 2014-11-10 Astellas Pharma Inc 4-(Indol-7-ylcarbonylaminomethyl)cyclohexancarboxylsyrederivater som EP4-receptorantagonister der er anvendelige til behandlingen af kronisk nyresvigt eller diabetisk nephropati
ES2610185T3 (es) * 2010-09-21 2017-04-26 Eisai R&D Management Co., Ltd. Composición farmacéutica
WO2012103071A2 (en) 2011-01-25 2012-08-02 Eisai R&D Management Co., Ltd. Compounds and compositions

Also Published As

Publication number Publication date
MX368098B (es) 2019-09-19
ES2684334T3 (es) 2018-10-02
PT3124480T (pt) 2018-10-04
CN106132945A (zh) 2016-11-16
EP3124480A4 (en) 2017-11-22
WO2015147020A1 (ja) 2015-10-01
AR099833A1 (es) 2016-08-24
CN106132945B (zh) 2019-04-26
PL3124480T3 (pl) 2018-10-31
KR20160138098A (ko) 2016-12-02
EP3124480B1 (en) 2018-07-11
CA2943778A1 (en) 2015-10-01
MX2016012318A (es) 2017-02-23
US20180030030A1 (en) 2018-02-01
US10106523B2 (en) 2018-10-23
TW201623277A (zh) 2016-07-01
RU2684906C2 (ru) 2019-04-16
JPWO2015147020A1 (ja) 2017-04-13
JP6428763B2 (ja) 2018-11-28
EP3124480A1 (en) 2017-02-01
RU2016141650A (ru) 2018-04-27

Similar Documents

Publication Publication Date Title
RU2017102236A3 (ru)
RU2018108828A3 (ru)
BR112016021943A2 (ru)
BR112016021595A2 (ru)
BR112016018154A2 (ru)
BR112016030490A2 (ru)
BR112016016193A2 (ru)
BR112016026722A2 (ru)
BR112016018021A2 (ru)
BR112016017135A2 (ru)
RU2016141650A3 (ru)
BR112016018653A2 (ru)
BR112016016459A2 (ru)
BR112016027829A2 (ru)
BR112016023276A2 (ru)
BR112016030591A2 (ru)
BR112016015729A2 (ru)
BR112016015878A2 (ru)
BR112016028071A2 (ru)
BR112016015346A2 (ru)
JP1522034S (ru)
JP1528120S (ru)
BR122018012705A2 (ru)
RU2016148736A3 (ru)
BR112016019360A2 (ru)